» Articles » PMID: 21793041

High CJD Infectivity Remains After Prion Protein is Destroyed

Overview
Journal J Cell Biochem
Date 2011 Jul 28
PMID 21793041
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The hypothesis that host prion protein (PrP) converts into an infectious prion form rests on the observation that infectivity progressively decreases in direct proportion to the decrease of PrP with proteinase K (PK) treatment. PrP that resists limited PK digestion (PrP-res, PrP(sc)) has been assumed to be the infectious form, with speculative types of misfolding encoding the many unique transmissible spongiform encephalopathy (TSE) agent strains. Recently, a PK sensitive form of PrP has been proposed as the prion. Thus we re-evaluated total PrP (sensitive and resistant) and used a cell-based assay for titration of infectious particles. A keratinase (NAP) known to effectively digest PrP was compared to PK. Total PrP in FU-CJD infected brain was reduced to ≤0.3% in a 2 h PK digest, yet there was no reduction in titer. Remaining non-PrP proteins were easily visualized with colloidal gold in this highly infectious homogenate. In contrast to PK, NAP digestion left 0.8% residual PrP after 2 h, yet decreased titer by >2.5 log; few residual protein bands remained. FU-CJD infected cells with 10× the infectivity of brain by both animal and cell culture assays were also evaluated. NAP again significantly reduced cell infectivity (>3.5 log). Extreme PK digestions were needed to reduce cell PrP to <0.2%, yet a very high titer of 8 logs survived. Our FU-CJD brain results are in good accord with the only other report on maximal PrP destruction and titer. It is likely that one or more residual non-PrP proteins may protect agent nucleic acids in infectious particles.

Citing Articles

"Prion-like" seeding and propagation of oligomeric protein assemblies in neurodegenerative disorders.

Zampar S, Di Gregorio S, Grimmer G, Watts J, Ingelsson M Front Neurosci. 2024; 18:1436262.

PMID: 39161653 PMC: 11330897. DOI: 10.3389/fnins.2024.1436262.


Prion disease modelled in Drosophila.

Bujdoso R, Smith A, Fleck O, Spiropoulos J, Andreoletti O, Thackray A Cell Tissue Res. 2022; 392(1):47-62.

PMID: 35092497 PMC: 10113284. DOI: 10.1007/s00441-022-03586-0.


Stability of BSE infectivity towards heat treatment even after proteolytic removal of prion protein.

Langeveld J, Balkema-Buschmann A, Becher D, Thomzig A, Nonno R, Andreoletti O Vet Res. 2021; 52(1):59.

PMID: 33863379 PMC: 8052740. DOI: 10.1186/s13567-021-00928-8.


Prion protein PrP nucleic acid binding and mobilization implicates retroelements as the replicative component of transmissible spongiform encephalopathy.

Lathe R, Darlix J Arch Virol. 2020; 165(3):535-556.

PMID: 32025859 PMC: 7024060. DOI: 10.1007/s00705-020-04529-2.


Viral Infections and Obesity.

Voss J, Dhurandhar N Curr Obes Rep. 2017; 6(1):28-37.

PMID: 28290153 DOI: 10.1007/s13679-017-0251-1.


References
1.
Manuelidis L, Chakrabarty T, Miyazawa K, Nduom N, Emmerling K . The kuru infectious agent is a unique geographic isolate distinct from Creutzfeldt-Jakob disease and scrapie agents. Proc Natl Acad Sci U S A. 2009; 106(32):13529-34. PMC: 2715327. DOI: 10.1073/pnas.0905825106. View

2.
Cronier S, Gros N, Tattum M, Jackson G, Clarke A, Collinge J . Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J. 2008; 416(2):297-305. PMC: 2584334. DOI: 10.1042/BJ20081235. View

3.
Manuelidis L . Decontamination of Creutzfeldt-Jakob disease and other transmissible agents. J Neurovirol. 1997; 3(1):62-5. DOI: 10.3109/13550289709015793. View

4.
Miyazawa K, Emmerling K, Manuelidis L . Replication and spread of CJD, kuru and scrapie agents in vivo and in cell culture. Virulence. 2011; 2(3):188-99. PMC: 3149681. DOI: 10.4161/viru.2.3.15880. View

5.
Somerville R, Gentles N . Characterization of the effect of heat on agent strains of the transmissible spongiform encephalopathies. J Gen Virol. 2011; 92(Pt 7):1738-1748. DOI: 10.1099/vir.0.030452-0. View